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   Ten patients with prostatitis were administered with Enoxacin (ENX), and the changes in its con-
centration in the seminal fluid were studied. For acute prostatitis patients, 600 mg/day of ENX was 
administered for 5 to 7 days, and for chronic prostatitis patients, 400 to 600 mg/day was administered for 
7 to 17 days. Seminal fluid was obtained in the morning of examination and frozen until measurement. 
ENX was measured by the agar well method using E. coli. The concentration of ENX was 2.69±0.85 
pg/m1 and 3.98±2.49 pg/ml in acute and chronic prostatitis patients, respectively, and there was no sig-
nificant difference between the two groups. When the dose and method of administration were compared, 
the mean ENX concentration was 3.65 pg/ml in the group administered 600 mg of ENX, while it was 2.60 
pg/ml in the group administered 400 mg of ENX and not significantly different. When ENX was 
administered for 7 days, the mean ENX concentration was 3.13 pg/ml, but when it was administered for 14 
days, it was 3.46 pg/ml slightly higher. These results indicate that since the concentration of ENX in the 
seminal fluid was higher than the minimum inhibitory concentration for the pathogens of prostatitis, ENX 
may be a clinically effective drug. 
                                             (Acta Urol. Jpn. 34: 1101-1103, 1988)
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症例 年齢 急性/一 日投与量(㎎)投 与 日数 エノキサシンの濃度(μg加の




























































































用量 と比較してみ ると,前 者は300mg/kg/day,で
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